MRCP UK EXAMINATIONS

Detailed explanation-1: -Early Treatment Diabetic Retinopathy Study (ETDRS)

Detailed explanation-2: -Treatment options for DME vary depending on the severity of disease and the patient’s baseline visual acuity (VA). However, on the basis of recent studies by the DRCR.net, discussed below, ophthalmologists have generally adopted anti-VEGF intravitreal therapy as the first-line treatment.

Detailed explanation-3: -Diabetic macular oedema is usually treated first with aflibercept or ranibizumab, which are already recommended by NICE for treating diabetic macular oedema if the eye has a central retinal thickness of 400 micrometres or more when treatment starts. Faricimab is another treatment option that works in a similar way.